The Adaptation of 12-Item Utah Photophobia Symptom Impact Scale (UPSIS-12) in Turkish, Internal Consistency, and Reproducibility.

Elif Ilgaz Aydınlar, Buse Rahime Hasırcı Bayır, Ozan Dörtkol, Elif Kocasoy Orhan, Esme Ekizoğlu, Betül Baykan, Mustafa Ertaş
Author Information
  1. Elif Ilgaz Aydınlar: Department of Neurology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey.
  2. Buse Rahime Hasırcı Bayır: Department of Neurology, Haydarpaşa Numune Training and Research Hospital, İstanbul, Turkey.
  3. Ozan Dörtkol: Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, Çapa, İstanbul, Turkey.
  4. Elif Kocasoy Orhan: Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, Çapa, İstanbul, Turkey.
  5. Esme Ekizoğlu: Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, Çapa, İstanbul, Turkey.
  6. Betül Baykan: Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, Çapa, İstanbul, Turkey.
  7. Mustafa Ertaş: Department of Neurology, İstanbul Faculty of Medicine, İstanbul University, Çapa, İstanbul, Turkey.

Abstract

Introduction: The 12-item Utah Photophobia Symptom Impact Scale (UPSIS-12) is a questionnaire to assess the impact of photophobia on daily living during and outside migraine episodes. We aimed to translate UPSIS-12 and assess its usability in the Turkish cohort by analyzing internal consistency, reliability, and reproducibility.
Methods: In this multicenter prospective, descriptive study, 120 patients with migraine were recruited. The patients received the diagnosis of migraine without aura (MwoA) and migraine with aura (MwA) according to the International Classification of Headache Disorders 3rd edition. The scale was translated into Turkish, and the patients were evaluated by headache experts in two visits four weeks apart from each other.
Results: The questionnaire showed highly correlated test-retest reliability (r=0.828). Cronbach alpha values of internal consistency revealed good to excellent results ranging from 0.78-0.82. There was a strong and positive correlation between self and physician-administered scales at both visits (r=0.964 and 0.985, respectively). The questionnaire was considered "well understood" by 95.6% of the patients. The average UPSIS-12 score of each visit was 25.8 and 26.9 (average standard deviation of 10.4). Subjects with MwoA (25.5±10.4) had remarkably lower mean scores compared to MwoA plus MwA (29.2±8.9) and MwA (32.9±9.4) (p=0.0167). Patients with high frequency migraine presented with a higher mean UPSIS-12 score than those with low frequency (31.3±9.5 and 24.7±9.8, respectively). It was noted that the mean UPSIS-12 scores of those with severe (29.4±9.4) and moderate ictal cutaneous allodynia (CA) (28.4±10.6) were higher than those without CA (22.0±9.3)(p=0.020).
Conclusion: The Turkish version of the UPSIS-12 questionnaire is a reliable tool and well-understood by the Turkish population. Patients with MwA, frequent migraine headache days and moderate to severe CA presented with higher scores. Given the independent burden of photophobia in migraineurs, the use of UPSIS-12 scale should be encouraged in Turkish population.

Keywords

References

  1. Cephalalgia. 2018 Jan;38(1):1-211 [PMID: 29368949]
  2. Cancer. 1950 Jan;3(1):32-5 [PMID: 15405679]
  3. Headache. 2015 Apr;55(4):600-4 [PMID: 25790126]
  4. Semin Neurol. 2019 Dec;39(6):739-748 [PMID: 31847045]
  5. Headache. 2020 Mar;60(3):506-514 [PMID: 31965576]
  6. Ann Neurol. 2000 May;47(5):614-24 [PMID: 10805332]
  7. Pain. 2019 Jul;160(7):1494-1501 [PMID: 31219950]
  8. Cephalalgia. 2009 Sep;29(9):953-9 [PMID: 19298545]
  9. Neurol Sci. 2013 May;34 Suppl 1:S133-5 [PMID: 23695062]
  10. Headache. 2004 Sep;44(8):786-93 [PMID: 15330825]
  11. Neurol Sci. 2022 Oct;43(10):6021-6030 [PMID: 35792969]
  12. Cephalalgia. 2016 May;36(6):526-33 [PMID: 26378082]
  13. Ann Neurol. 2008 Feb;63(2):148-58 [PMID: 18059010]
  14. Cephalalgia. 2019 Oct;39(11):1445-1454 [PMID: 31116567]
  15. J Thorac Oncol. 2010 Sep;5(9):1315-6 [PMID: 20736804]
  16. J Headache Pain. 2015 Feb 15;16:14 [PMID: 25904144]
  17. Neurol Sci. 2012 May;33 Suppl 1:S9-11 [PMID: 22644161]
  18. Curr Opin Neurol. 2011 Jun;24(3):197-202 [PMID: 21467933]
  19. Cephalalgia. 2021 Oct;41(11-12):1240-1248 [PMID: 33990148]
  20. Headache. 2008 Mar;48(3):395-7 [PMID: 17868350]
  21. Cephalalgia. 2013 Apr;33(6):365-74 [PMID: 23359872]
  22. Headache. 1997 Sep;37(8):492-5 [PMID: 9329231]
  23. Clin J Pain. 2016 Jul;32(7):631-5 [PMID: 26379076]
  24. Cephalalgia. 2016 Feb;36(2):139-47 [PMID: 25926619]
  25. Noro Psikiyatr Ars. 2017 Sep;54(3):260-266 [PMID: 29033640]
  26. Headache. 2020 Feb;60(2):416-429 [PMID: 31837007]
  27. Neurology. 2001;56(6 Suppl 1):S20-8 [PMID: 11294956]

Word Cloud

Created with Highcharts 10.0.0UPSIS-12migraineTurkishquestionnairepatientsMwA4photophobiaMwoAmeanscoreshigherCAUtahPhotophobiaSymptomImpactScaleassessimpactinternalconsistencyreliabilitywithoutaurascaleheadachevisitsr=00respectivelyaveragescore258929p=0PatientsfrequencypresentedseveremoderatepopulationIntroduction:12-itemdailylivingoutsideepisodesaimedtranslateusabilitycohortanalyzingreproducibilityMethods:multicenterprospectivedescriptivestudy120recruitedreceiveddiagnosisaccordingInternationalClassificationHeadacheDisorders3rdeditiontranslatedevaluatedexpertstwofourweeksapartotherResults:showedhighlycorrelatedtest-retest828Cronbachalphavaluesrevealedgoodexcellentresultsranging78-082strongpositivecorrelationselfphysician-administeredscales964985considered"wellunderstood"956%visit26standarddeviation10Subjects5±10remarkablylowercomparedplus2±8329±90167highlow313±95247±9noted4±9ictalcutaneousallodynia284±106220±93020Conclusion:versionreliabletoolwell-understoodfrequentdaysGivenindependentburdenmigraineursuseencouragedAdaptation12-ItemInternalConsistencyReproducibilityLightsensitivitysymptom

Similar Articles

Cited By

No available data.